The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. by country

Countries reporting
146
Highest
115.63
Italy
Lowest
0
Vanuatu
Median
88.25
Years covered
5
2017–2021
Data points
740

What the numbers show

The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. is currently reported for 146 countries. The highest value is 115.63 in Italy; the lowest is 0 in Vanuatu.

The median across all reporting countries is 88.25, and the mean is 75.95.

The number of people with susceptibility test result for rifampicin: full country ranking

#Country LatestYear 10-year changeTrend
1 Italy 115.63 2021 rising
2 Andorra 100 2021 rising
2 Armenia 100 2021 flat
2 Bahamas 100 2021 flat
2 Belarus 100 2021 flat
2 Bermuda 100 2021 flat
2 Brunei Darussalam 100 2021 flat
2 Micronesia, Federated States of 100 2021 falling
2 Israel 100 2021 flat
2 Jamaica 100 2021 rising
2 Kuwait 100 2021 flat
2 Lao People's Democratic Republic 100 2021 rising
2 Saint Lucia 100 2021 falling
2 Lithuania 100 2021 flat
2 Marshall Islands 100 2021 falling
2 North Macedonia 100 2021 flat
2 Montenegro 100 2021 flat
2 Mongolia 100 2021 rising
2 Northern Mariana Islands 100 2021 rising
2 Mauritius 100 2021 flat
2 New Caledonia 100 2021 flat
2 Naoero 100 2021 volatile
2 Palau 100 2021 flat
2 Qatar 100 2021 flat
2 Eswatini 100 2021 rising
2 Seychelles 100 2021 flat
2 Chad 100 2021 volatile
2 Tajikistan 100 2021 flat
2 Tonga 100 2021 flat
2 Tuvalu 100 2021 falling
2 Uzbekistan 100 2021 flat
32 Kazakhstan 99.88 2021 rising
33 Georgia 99.79 2021 flat
34 Macau, China 98.97 2021 flat
35 Singapore 98.69 2021 flat
36 Norway 98.57 2021 flat
37 Slovenia 98.31 2021 flat
38 Bosnia and Herzegovina 97.7 2021 rising
39 Ukraine 97.48 2021 flat
40 Bhutan 96.77 2021 rising
41 Kiribati 96.72 2021 rising
42 Sweden 96.65 2021 flat
43 Denmark 96.58 2021 flat
44 Republic of Moldova 96.4 2021 flat
45 Fiji 96.21 2021 falling
46 Chile 96.15 2021 rising
47 Azerbaijan 96.11 2021 flat
48 Estonia 96.1 2021 flat
49 Ghana 96.1 2021 flat
50 Maldives 95.83 2021 rising
51 Guatemala 95.02 2021 rising
52 Hong Kong, China 94.83 2021 flat
53 United States of America 94.32 2021 rising
54 Bahrain 94.12 2021 falling
55 Peru 94.02 2021 rising
56 Kyrgyzstan 94.01 2021 rising
57 Russian Federation 93.52 2021 rising
58 Puerto Rico 93.33 2021 flat
59 Malta 93.1 2021 flat
60 Paraguay 92.7 2021 rising
61 Togo 92.42 2021 volatile
62 Guam 92.11 2021 falling
63 Pakistan 91.93 2021 rising
64 Albania 91.67 2021 volatile
65 Poland 91.55 2021 flat
66 Lebanon 91.2 2021 flat
67 Tanzania, United Republic of 90.17 2021 rising
68 Czechia 89.51 2021 flat
69 Romania 89.23 2021 flat
70 Guinea-Bissau 89.04 2021 volatile
71 Egypt 89 2021 rising
72 Viet Nam 88.85 2021 rising
73 Philippines 88.57 2021 volatile
74 Benin 87.94 2021 volatile
75 United Kingdom of Great Britain and Northern Ireland 87.93 2021 falling
76 Cyprus 87.88 2021 flat
77 Türkiye 87.71 2021 flat
78 Dominican Republic 87.56 2021 volatile
79 Switzerland 87.3 2021 flat
80 Austria 86.84 2021 flat
81 Belgium 86.27 2021 falling
82 Netherlands 86.26 2021 falling
83 Finland 86.14 2021 falling
84 Zambia 85.35 2021 rising
85 Slovakia 84.42 2021 flat
86 Malaysia 84.34 2021 rising
87 Oman 84.21 2021 falling
88 Hungary 84.02 2021 falling
89 Germany 83.72 2021 flat
90 Australia 83.5 2021 falling
91 Korea 82.06 2021 flat
92 Nepal 81.26 2021 volatile
93 Uruguay 80.19 2021 falling
94 Ireland 80 2021 falling
95 China 79.92 2021 rising
96 Sudan 79.91 2021 volatile
97 Jordan 78.48 2021 rising
98 India 76.27 2021 rising
99 Thailand 76.11 2021 rising
100 Nigeria 76 2021 rising
101 Uganda 74.76 2021 flat
102 Indonesia 72.55 2021 rising
103 Afghanistan 70.58 2021 rising
104 United Arab Emirates 69.7 2021 flat
105 Cape Verde 69.01 2021 rising
106 Burkina Faso 67.26 2021 rising
107 Kenya 63.13 2021 rising
108 Japan 62.2 2021 falling
109 Croatia 60.19 2021 volatile
110 Trinidad and Tobago 59.38 2021 falling
111 Côte d'Ivoire 59.19 2021 volatile
112 Portugal 54.52 2021 falling
113 Equatorial Guinea 54.36 2021 volatile
114 Brazil 50.47 2021 rising
115 Bulgaria 47.71 2021 falling
116 Iran, Islamic Republic of 46.76 2021 falling
117 Nicaragua 46.72 2021 rising
118 Solomon Islands 45.52 2021 volatile
119 Greece 45.08 2021 rising
120 Guinea 44.93 2021 volatile
121 Bangladesh 43.54 2021 rising
122 Congo 42.71 2021 volatile
123 Honduras 42.38 2021 flat
124 Cuba 40.43 2021 falling
125 Colombia 39.17 2021 rising
126 Liberia 37.16 2021 falling
127 Argentina 36.41 2021 rising
128 Mexico 35.3 2021 volatile
129 Saudi Arabia 33.85 2021 falling
130 Angola 33.12 2021 volatile
131 Gabon 32.55 2021 volatile
132 Senegal 30.79 2021 volatile
133 Iraq 29.8 2021 volatile
134 Mali 26.76 2021 volatile
135 El Salvador 26.6 2021 falling
136 Congo, Democratic Republic of the 22.3 2021 volatile
137 Madagascar 15.83 2021 volatile
138 Niger 11.2 2021 volatile
139 Central African Republic 9.75 2021 volatile
140 Venezuela, Bolivarian Republic of 3.31 2021 falling
141 France 1.45 2021 volatile
142 Grenada 0 2021 volatile
142 Mauritania 0 2021 volatile
142 South Sudan 0 2021 volatile
142 Sao Tome and Principe 0 2021 volatile
142 Vanuatu 0 2021 volatile

Regions and income groups

Aggregates are excluded from the country ranking above so that a region can never outrank a country.

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin by country. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 13 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among-2/">The number of people with susceptibility test result for rifampicin by country</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
148 places, 740 data points, 2017–2021
Last refreshed